About
LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS). The Cardiopulmonary segment is involved in the design, development, manufacture, marketing and selling of cardiopulmonary products. The Neuromodulation segment is associated in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating DRE and DTD. The ACS segment deals with the design, development, manufacture, marketing and selling of temporary life support products. The company was founded in 1987 and is headquartered in London, the United Kingdom.
Current Value
$38.281 Year Return
Current Value
$38.281 Year Return
Key Details
Market Cap
$2.15B
P/E Ratio
34.4
1Y Stock Return
-26.77%
1Y Revenue Growth
8.33%
Dividend Yield
0.00%
Price to Book
1.6
Strategies that include LIVN
Double maintains 2 strategies that include LIVN - LivaNova Plc
Medium risk
$13,000
0.04%
Health Care Sector
This Strategy focuses on healthcare companies, including pharmaceuticals, biotechnology, healthcare providers, and medical equipment firms. Offering exposure to a sector driven by demographic trends and ongoing medical advancements, it's a strategic choice for investors considering healthcare's long-term growth potential.
Top Sector
Health Care
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
348
Medium risk
$5,000
0.08%US Mid Cap
This strategy tracks a market-cap-weighted index of mid-cap US companies. This strategy offers targeted exposure to the growth potential of mid-sized businesses within the US market. With a diversified portfolio of holdings, it provides investors with a comprehensive approach to capturing the mid-cap segment's performance.
Top Sector
Industrials
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
401
Stock's related to LIVN
The stocks that are correlated to LIVN - LivaNova Plc are XHR, SRE, ENOV, CIVI, OSW
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| 44.58% | $1.20B | -20.91% | 4.69% | |
S SRESempra | 44.53% | $47.45B | +2.63% | 3.48% |
E ENOVEnovis Corp. | 42.57% | $2.11B | -37.68% | 0.00% |
| 41.98% | $3.26B | -52.00% | 6.64% | |
| 41.45% | $1.79B | +31.44% | 0.77% | |
| 40.86% | $5.05B | +3.77% | 0.03% | |
| 40.81% | $31.12B | +29.22% | 0.00% | |
| 40.65% | $6.46B | +68.76% | 0.00% | |
A AORTArtivion, Inc. | 40.51% | $1.05B | +16.78% | 0.00% |
| 40.33% | $7.64B | +14.08% | 1.81% | |
| 39.96% | $6.57B | +67.27% | 0.00% | |
A ATENA10 Networks, Inc. | 39.17% | $1.24B | +25.54% | 1.54% |
T TPGTPG, Inc. | 39.09% | $5.31B | +10.19% | 4.04% |
| 38.99% | $16.85B | +45.16% | 1.93% | |
| 38.97% | $10.01B | +25.23% | 2.01% | |
P PHINPHINIA, Inc. | 38.72% | $1.79B | +11.89% | 2.52% |
| 38.66% | $1.22B | +22.77% | 0.00% | |
| 38.21% | $147.98B | +46.85% | 0.00% | |
I IVZInvesco Ltd. | 37.71% | $7.02B | -5.94% | 5.88% |
| 37.61% | $54.25B | +9.51% | 5.48% | |
ETF's related to LIVN
The ETFs that are correlated to LIVN - LivaNova Plc are CPRJ, XHE, RSPA, FSMD, FXO
Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| 48.39% | $48.38M | 0.69% | |
| 48.34% | $174.19M | 0.35% | |
| 47.18% | $292.67M | 0% | |
| 42.03% | $1.10B | 0.16% | |
| 41.88% | $2.14B | 0.62% | |
| 41.43% | $477.17M | 0.35% | |
| 40.77% | $19.92B | 0.05% | |
| 40.68% | $1.76B | 0.17% | |
| 40.54% | $704.38M | 0.38% | |
| 40.53% | $2.75B | 0.07% | |
| 40.51% | $3.71B | 0.39% | |
| 40.31% | $1.12B | 0.6% | |
| 40.15% | $1.10B | 0.31% | |
| 40.13% | $514.19M | 0.2% | |
| 40.12% | $833.42M | 0.6% | |
| 40.00% | $1.37B | 0.47% | |
| 39.98% | $15.94B | 0.04% | |
| 39.95% | $10.95B | 0.24% | |
| 39.84% | $2.34B | 0.39% | |
| 39.82% | $62.65B | 0.19% | |
News
Yahoo
LONDON, March 26, 2025--LivaNova PLC will host a conference call to discuss its first-quarter 2025 results on Wed., May 7, 2025, at 1 p.m. London time (8 a.m. Eastern Time).
Yahoo
As an investor its worth striving to ensure your overall portfolio beats the market average. But in any portfolio...
Finnhub
LivaNova PLC: * LIVANOVA PLC - SUPREME COURT RULES LIVANOVA NOT LIABLE FOREUR157 MILLION PAYMENTS IN ENVIRONMENTAL LIABILITIES CASE * LIVANOVA PLC - TO RECORD EUR333...
Yahoo
Investors were underwhelmed by the solid earnings posted by LivaNova PLC ( NASDAQ:LIVN ) recently. Our analysis says...
Yahoo
We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts. In this article, we are going to take a look at where LivaNova PLC (NASDAQ:LIVN) stands against the other medical technology stocks. Growth and Drivers of the Global MedTech Market The MedTech sector is crucial in healthcare, which concentrates […]
SeekingAlpha
Tracking David Einhorn's Greenlight Capital Portfolio - Q4 2024 Update
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
0% Expense Ratios with TLH
We offer over 50 indexes with zero expense ratios.
Registration will take about 10 seconds